Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.44 USD | +2.54% | -1.55% | +4.23% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 274M 21.96B |
---|---|---|---|---|---|
Net income 2024 * | -94M -7.52B | Net income 2025 * | -119M -9.53B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.08
x | P/E ratio 2025 * |
-2.82
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Inozyme Pharma, Inc.
1 day | +2.54% | ||
1 week | -1.55% | ||
Current month | -42.04% | ||
1 month | -34.51% | ||
3 months | -5.73% | ||
6 months | +57.45% | ||
Current year | +4.23% |
Managers | Title | Age | Since |
---|---|---|---|
Axel Bolte
FOU | Founder | 52 | 31/08/15 |
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 30/04/20 |
Director of Finance/CFO | 48 | 30/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 30/04/20 |
Reinaldo Diaz
BRD | Director/Board Member | 70 | 31/12/16 |
Axel Bolte
FOU | Founder | 52 | 31/08/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 4.44 | +2.54% | 511,357 |
25/04/24 | 4.33 | -1.59% | 627,485 |
24/04/24 | 4.4 | 0.00% | 478,912 |
23/04/24 | 4.4 | +0.23% | 742,573 |
22/04/24 | 4.39 | -2.66% | 813,172 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.23% | 274M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- INZY Stock